Keros Therapeutics, Inc.

financial.report · SEC EDGAR

This page reproduces a recorded source event. It is not a live quote, forecast, recommendation or legal conclusion.

Event type

financial.report

Occurred

2025-12-31

Reported

2026-03-04

Disclosure lag

63 days

Context

links are based on the recorded entity type

Field	Recorded value
Entity	Keros Therapeutics, Inc.
Source	SEC EDGAR ↗
Source identifier	companyfacts/CIK0001664710/2026-07-26
Event ID	#29260

Recorded payload

JSON payload as stored after parsing

{
  "accession": "0001664710-26-000018",
  "canonical_covered": 11,
  "canonical_total": 12,
  "fiscal_period": "FY",
  "fiscal_year": 2025,
  "form": "10-K",
  "mapped_tag_share": 0.053497942386831275,
  "metrics": {
    "cash_and_equivalents": 287415000,
    "earnings_per_share_basic": 2.34,
    "earnings_per_share_diluted": 2.3,
    "net_income": 87014000,
    "operating_cash_flow": 107505000,
    "operating_income": 67569000,
    "revenue": 243864000,
    "shareholders_equity": 303132000,
    "shares_outstanding": 19543706,
    "total_assets": 338021000,
    "total_liabilities": 34889000
  },
  "metrics_reported": 11,
  "period_end": "2025-12-31"
}

Source: SEC EDGAR · as of 2026-03-04T00:00:00Z